The human microbiome

Advances in Medical Sciences

Volumn 62, Issue 2, 2017, Pages 414-420

  Blum, Hubert E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Atherosclerosis; Fecal transplantation; Inflammatory bowel disease; Microbiota; Neurodegenerative diseases; Obesity

Indexed keywords

NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COLON CANCER; DEGENERATIVE DISEASE; HELMINTHIASIS; HUMAN; HUMAN MICROBIOME PROJECT; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MENTAL DISEASE; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBOSIS; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM; BIODIVERSITY; DISEASES; MICROFLORA;

BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIODIVERSITY; DISEASE; HUMANS; MICROBIOTA;

EID: 85023186212     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2017.04.005     Document Type: Review

References (89)

1. Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., et al. Initial sequencing and analysis of the human genome. Nature 409 (2001), 860–921.
2. Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., et al. The sequence of the human genome. Science 291 (2001), 1304–1351.
3. Manolio, T.A., Brooks, L.D., Collins, F.S., A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118 (2008), 1590–1605.
4. Manolio, T.A., Collins, F.S., The HapMap and genome-wide association studies in diagnosis and therapy. Annu Rev Med 60 (2009), 443–456.
5. Hou, L., Heilbronner, U., Degenhardt, F., Adli, M., Akiyama, K., Akula, N., et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet 387:10023 (2016), 1085–1093.
6. Proctor, L.M., The human microbiome project in 2011 and beyond. Cell Host Microbe 10 (2011), 287–291.
7. Spor, A., Koren, O., Ley, R., Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 9 (2011), 279–290.
8. Human Microbiome Project C, Structure, function and diversity of the healthy human microbiome. Nature 486 (2012), 207–214.
9. Human Microbiome Project C, A framework for human microbiome research. Nature 486 (2012), 215–221.
10. Gevers, D., Knight, R., Petrosino, J.F., Huang, K., McGuire, A.L., Birren, B.W., et al. The Human Microbiome Project: a community resource for the healthy human microbiome. PLoS Biol, 10, 2012, e1001377.
11. Morgan, X.C., Segata, N., Huttenhower, C., Biodiversity and functional genomics in the human microbiome. Trends Genet 29 (2013), 51–58.
12. Rossen, N.G., Fuentes, S., van der Spek, M.J., Tijssen, J.G., Hartman, J.H., et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149 (2015), 110–118.
13. Lynch, S.V., Pedersen, O., The human intestinal microbiome in health and disease. N Engl J Med 375 (2016), 2369–2379.
14. Li, J., Jia, H., Cai, X., Zhong, H., Feng, Q., Sunagawa, S., et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol 32 (2014), 834–841.
15. Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
16. Zhernakova, A., Kurilshikov, A., Bonder, M.J., Tigchelaar, E.F., Schirmer, M., Vatanen, T., et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352 (2016), 565–569.
17. Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564.
18. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107 (2010), 14691–14696.
19. Trompette, A., Gollwitzer, E.S., Yadava, K., Sichelstiel, A.K., Sprenger, N., Ngom-Bru, C., et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med. 20 (2014), 159–166.
20. Cho, I., Yamanishi, S., Cox, L., Methe, B.A., Zavadil, J., Li, K., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488 (2012), 621–626.
21. Maurice, C.F., Haiser, H.J., Turnbaugh, P.J., Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 152 (2013), 39–50.
22. Fujimura, K.E., Demoor, T., Rauch, M., Faruqi, A.A., Jang, S., Johnson, C.C., et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci U S A 111 (2014), 805–810.
23. Fujimura, K.E., Sitarik, A.R., Havstad, S., Lin, D.L., Levan, S., Fadrosh, D., et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med 22 (2016), 1187–1191.
24. Goodrich, J.K., Waters, J.L., Poole, A.C., Sutter, J.L., Koren, O., Blekhman, R., et al. Human genetics shape the gut microbiome. Cell 159 (2014), 789–799.
25. Xavier, R.J., Podolsky, D.K., Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007), 427–434.
26. Hall, L.J., Walshaw, J., Watson, A.J., Gut microbiome in new-onset Crohn's disease. Gastroenterology 147 (2014), 932–934.
27. Sha, S., Xu, B., Wang, X., Zhang, Y., Wang, H., Kong, X., et al. The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. Diagn Microbiol Infect Dis 75 (2013), 245–251.
28. Frank, D.N., St Amand, A.L., Feldman, R.A., Boedeker, E.C., Harpaz, N., Pace, N.R., Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104 (2007), 13780–13785.
29. Peterson, D.A., Frank, D.N., Pace, N.R., Gordon, J.I., Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 3 (2008), 417–427.
30. Ramanan, D., Bowcutt, R., Lee, S.C., Tang, M.S., Kurtz, Z.D., Ding, Y., et al. Helminth infection promotes colonization resistance via type 2 immunity. Science 352 (2016), 608–612.
31. Moschen, A.R., Gerner, R.R., Wang, J., Klepsch, V., Adolph, T.E., Reider, S.J., et al. Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations. Cell Host Microbe 19 (2016), 455–469.
32. Belkaid, Y., Hand, T.W., Role of the microbiota in immunity and inflammation. Cell 157 (2014), 121–141.
33. Weinstock, J.V., Elliott, D.E., Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis 15 (2009), 128–133.
34. Cleynen, I., Boucher, G., Jostins, L., Schumm, L.P., Zeissig, S., Ahmad, T., et al. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet 387 (2016), 156–167.
35. Ramanan, D., Tang, M.S., Bowcutt, R., Loke, P., Cadwell, K., Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity 41 (2014), 311–324.
36. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E.G., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368 (2013), 407–415.
37. Youngster, I., Russell, G.H., Pindar, C., Ziv-Baran, T., Sauk, J., et al. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 312 (2014), 1772–1778.
38. Moayyedi, P., Suree, M.G., Kim, P.T., Libertucci, J., Wolfe, M., et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149 (2015), 102–109.
39. Paramsothy, S., Kamm, M.A., Kaakoush, N.O., Walsh, A.J., van den Bogaerde, J., et al. Multi-donor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placeb-controlled trial. Lancet 389 (2017), 1218–1228.
40. Konishi, H., Fujiya, M., Tanaka, H., Ueno, N., Moriichi, K., Sasajima, J., et al. Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis. Nat Commun, 7, 2016, 12365.
41. Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
42. Pedersen, H.K., Gudmundsdottir, V., Nielsen, H.B., Hyotylainen, T., Nielsen, T., Jensen, B.A., et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535 (2016), 376–381.
43. Smith, M.I., Yatsunenko, T., Manary, M.J., Trehan, I., Mkakosya, R., Cheng, J., et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 339 (2013), 548–554.
44. Subramanian, S., Huq, S., Yatsunenko, T., Haque, R., Mahfuz, M., Alam, M.A., et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 510 (2014), 417–421.
45. Vrieze, A., Van Nood, E., Holleman, F., Salojarvi, J., Kootte, R.S., Bartelsman, J.F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology, 143, 2012 e913-6 e7.
46. Koeth, R.A., Wang, Z., Levison, B.S., Buffa, J.A., Org, E., Sheehy, B.T., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19 (2013), 576–585.
47. Zhu, W., Gregory, J.C., Org, E., Buffa, J.A., Gupta, N., Wang, Z., et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165 (2016), 111–124.
48. Wang, Z., Roberts, A.B., Buffa, J.A., Levison, B.S., Zhu, W., Org, E., et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163 (2015), 1585–1595.
49. Fung, T.C., Olson, C.A., Hsiao, E.Y., Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci 20 (2017), 145–155.
50. Sampson, T.R., Mazmanian, S.K., Control of brain development, function, and behavior by the microbiome. Cell Host Microbe. 17 (2015), 565–576.
51. Fasano, A., Visanji, N.P., Liu, L.W., Lang, A.E., Pfeiffer, R.F., Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 14 (2015), 625–639.
52. Shannon, K.M., Keshavarzian, A., Mutlu, E., Dodiya, H.B., Daian, D., Jaglin, J.A., et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord 27 (2012), 709–715.
53. Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell, 167, 2016 1469-80 e12.
54. Erny, D., Hrabe de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci 18 (2015), 965–977.
55. Costello, E.K., Lauber, C.L., Hamady, M., Fierer, N., Gordon, J.I., Knight, R., Bacterial community variation in human body habitats across space and time. Science 326 (2010), 1694–1697.
56. Edmonds-Wilson, S.L., Nurinova, N.I., Zapka, C.A., Fierer, N., Wilson, M., Review of human hand microbiome research. J Dermatol Sci 80 (2015), 3–12.
57. Fierer, N., Lauber, C.L., Zhou, N., McDonald, D., Costello, E.K., Knight, R., Forensic identification using skin bacterial communities. Proc Natl Acad Sci USA 107 (2010), 6477–6481.
58. Honda, K., Littman, D.R., The microbiota in adaptive immune homeostasis and disease. Nature 535 (2016), 75–84.
59. Vatanen, T., Kostic, A.D., d'Hennezel, E., Siljander, H., Franzosa, E.A., Yassour, M., et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165 (2016), 842–853.
60. Thaiss, C.A., Zmora, N., Levy, M., Elinav, E., The microbiome and innate immunity. Nature 535 (2016), 65–74.
61. Ijssennagger, N., Belzer, C., Hooiveld, G.J., Dekker, J., van Mil, S.W., Muller, M., et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc Natl Acad Sci U S A 112 (2015), 10038–10043.
62. Reinhardt, C., Bergentall, M., Greiner, T.U., Schaffner, F., Ostergren-Lunden, G., Petersen, L.C., et al. Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature 483 (2012), 627–631.
63. Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161 (2015), 264–276.
64. Ege, M.J., Mayer, M., Normand, A.C., Genuneit, J., Cookson, W.O., Braun-Fahrlander, C., et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 364 (2011), 701–709.
65. Lynch, S.V., Wood, R.A., Boushey, H., Bacharier, L.B., Bloomberg, G.R., Kattan, M., et al. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. J Allergy Clin Immunol, 134, 2014 593-601 e12.
66. Stein, M.M., Hrusch, C.L., Gozdz, J., Igartua, C., Pivniouk, V., Murray, S.E., et al. Innate immunity and asthma risk in amish and hutterite farm children. N Engl J Med. 375 (2016), 411–421.
67. Jonsson, A.L., Backhed, F., Drug the Bug!. Cell 163 (2015), 1565–1566.
68. Tilg, H., A gut feeling about thrombosis. N Engl J Med 374 (2016), 2494–2496.
69. Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (2011), 57–63.
70. Tang, W.H., Wang, Z., Levison, B.S., Koeth, R.A., Britt, E.B., Fu, X., et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 368 (2013), 1575–1584.
71. Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun, 6, 2015, 6528.
72. Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350 (2015), 1084–1089.
73. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60.
74. Forbes, J.D., Van Domselaar, G., Bernstein, C.N., Microbiome survey of the inflamed and noninflamed gut at different compartments within the gastrointestinal tract of inflammatory bowel disease patients. Inflamm Bowel Dis 22 (2016), 817–825.
75. Forbes, J.D., Van Domselaar, G., Bernstein, C.N., The gut microbiota in immune-mediated inflammatory diseases. Front Microbiol, 7, 2016, 1081.
76. Cantarel, B.L., Waubant, E., Chehoud, C., Kuczynski, J., DeSantis, T.Z., Warrington, J., et al. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J Invest Med 63 (2015), 729–734.
77. Jangi, S., Gandhi, R., Cox, L.M., Li, N., von Glehn, F., Yan, R., et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun, 7, 2016, 12015.
78. Chen, J., Wright, K., Davis, J.M., Jeraldo, P., Marietta, E.V., Murray, J., et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med., 8, 2016, 43.
79. Scher, J.U., Ubeda, C., Artacho, A., Attur, M., Isaac, S., Reddy, S.M., et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 67 (2015), 128–139.
80. Haque, T.R., Barritt ASt Intestinal microbiota in liver disease. Best Pract Res Clin Gastroenterol 30 (2016), 133–142.
81. Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513 (2014), 59–64.
82. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
83. Shen, J., Obin, M.S., Zhao, L., The gut microbiota, obesity and insulin resistance. Mol Aspects Med 34 (2013), 39–58.
84. Mazidi, M., Rezaie, P., Kengne, A.P., Mobarhan, M.G., Ferns, G.A., Gut microbiome and metabolic syndrome. Diabetes Metab Syndr 10 (2016), S150–7.
85. Sonnenburg, J.L., Backhed, F., Diet-microbiota interactions as moderators of human metabolism. Nature 535 (2016), 56–64.
86. Choi, G.B., Yim, Y.S., Wong, H., Kim, S., Kim, H., Kim, S.V., et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351 (2016), 933–939.
87. Aizawa, E., Tsuji, H., Asahara, T., Takahashi, T., Teraishi, T., Yoshida, S., et al. Possible association of Bifidobacterium and Lactobacillus in the gut microbiota of patients with major depressive disorder. J Affect Disord 202 (2016), 254–257.
88. Bu, X.L., Yao, X.Q., Jiao, S.S., Zeng, F., Liu, Y.H., Xiang, Y., et al. A study on the association between infectious burden and Alzheimer's disease. Eur J Neurol 22 (2015), 1519–1525.
89. Scheperjans, F., Aho, V., Pereira, P.A., Koskinen, K., Paulin, L., Pekkonen, E., et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 30 (2015), 350–358.